Prolonged response to first-line erlotinib for advanced lung adenocarcinoma
<p>Abstract</p> <p>A 58-year-old, non-smoking female of Philippine origin presented with painful thoracic and neck nodal relapse of lung adenocarcinoma almost 5 years after left pneumonectomy for stage II non-small-cell lung cancer. She refused conventional chemotherapy or radiatio...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-11-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Online Access: | http://www.jeccr.com/content/27/1/59 |